natgillin/translations-raw huggingface dataset:
MabCampath 10 mg/ ml concentrate for solution for infusion Alemtuzumab Intravenous use
MabCampath 10 mg/ ml koncentrat za raztopino za infundiranje alemtuzumab Intravenska uporaba
MabCampath 30 mg/ ml concentrate for solution for infusion Alemtuzumab
MabCampath 30 mg/ ml koncentrat za raztopino za infundiranje alemtuzumab
3 x 1 ml vials 30 mg/ ml
3 x 1 ml viale 30 mg/ ml
Store in the original package in order to protect from light,.
42 Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
MARKETING AUTHORISATION NUMBER (S)
ŠTEVILKA( E) DOVOLJENJA( DOVOLJENJ) ZA PROMET
41 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
43 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
MabCampath 30 mg/ ml concentrate for solution for infusion Alemtuzumab Intravenous use
MabCampath 30 mg/ ml koncentrat za raztopino za infundiranje alemtuzumab Intravenska uporaba
You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Morda ga boste želeli ponovno prebrati. • Če imate kakršnakoli dodatna vprašanja, se posvetujte z zdravnikom ali farmacevtom. • Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
What MabCampath is and what it is used for 2.
Kaj je zdravilo MabCampath in za kaj ga uporabljamo 2.
Before you are given MabCampath 3.
Kaj morate vedeti preden boste uporabili zdravilo MabCampath 3.
How MabCampath is used 4.
Kako uporabljati zdravilo MabCampath 4.
How to store MabCampath 6.
Shranjevanje zdravila MabCampath 6.
MabCampath is a monoclonal antibody.
Zdravilo MabCampath je monoklonsko protitelo.
Monoclonal antibodies are proteins which specifically recognise and bind to a unique other protein called an antigen.
Monoklonska protitelesa so beljakovine, ki posebej prepoznajo in se vežejo na povsem določeno drugo beljakovino, imenovano antigen.
MabCampath binds to an antigen on the surface of certain white blood cells, called lymphocytes.
Zdravilo MabCampath se veže na antigen na površini določenih belih krvnih celic, imenovanih limfociti.
Patients with chronic lymphocytic leukaemia (CLL) have too many abnormal lymphocytes, which displace healthy cells in the bone marrow where most new blood cells are formed.
Bolniki s kronično limfocitno levkemijo (KLL) imajo preveč nenormalnih limfocitov in ti izpodrivajo zdrave krvne celice v kostnem mozgu, kjer nastaja večina novih krvnih celic.
This replacement of healthy cells also happens in the blood stream and other organs.
Zdrave celice izpodrivajo tudi v krvnem obtoku in drugih organih.
After binding to the abnormal lymphocytes, MabCampath destroys them, and they are gradually removed from the body by normal biological processes.
Zdravilo MabCampath se veže na nenormalne limfocite in jih uniči, potem pa se iz telesa postopoma odstranijo z normalnimi biološkimi dogajanji.
MabCampath is used for the treatment of B-cell chronic lymphocytic leukaemia (B-CLL) in cases where fludarabine combination chemotherapy is not appropriate for you.
Zdravilo MabCampath se uporablja za zdravljenje bolnikov z B- celično kronično limfocitno levkemijo (B- KLL), za katere kemoterapija s fludarabinom ni primerna.
BEFORE YOU ARE GIVEN MABCAMPATH
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO MABCAMPATH
Do not use MabCampath if you:
Ne uporabljajte zdravila MabCampath, če
• are allergic to alemtuzumab or to proteins of a similar origin or to any of the other ingredients of MabCampath.
• ste alergični na (preobčutljivi za) alemtuzumab, beljakovine podobnega izvora ali katerokoli sestavino zdravila MabCampath.
Your doctor will inform you accordingly • have an infection • have HIV • have an active second malignancy • are pregnant (see also below).
O tem vam bo ustrezno svetoval zdravnik. • imate kakšno okužbo • ste okuženi z virusom HIV • imate aktivno drugo maligno bolezen • ste noseči (glejte tudi v nadaljevanju).
Take special care with MabCampath:
46 Bodite posebno pozorni pri uporabi zdravila MabCampath
When you first receive MabCampath, you may experience side effects soon after the first infusions (see section 4 “ Possible side effects”).
Možni neželeni učinki).
44 You may also be given
Zdravnik vam bo morda predpisal tudi
• steroids, antihistamines or analgesics (treatment for fever) to help to reduce some of the side effects.
• steroide, antihistaminike ali analgetike (proti zvišani telesni temperaturi), ki bodo pomagali zmanjšati nekatere neželene učinke.
MabCampath treatment may reduce your natural resistance to infections
Zdravljenje z zdravilom MabCampath lahko zmanjša vašo naravno odpornost proti okužbam
• antibiotics and antivirals may be given to provide you with extra protection.
• za dodatno zaščito boste morda dobili antibiotike in protivirusna zdravila.
You will be examined for symptoms of a certain type of viral infection called CMV (cytomegalovirus) during your MabCampath therapy and for at least 2 months afterwards.
Med zdravljenjem z zdravilom MabCampath in še vsaj dva meseca po tem bo zdravnik preverjal, če imate simptome določene virusne okužbe, imenovane CMV (citomegalovirus).
• have heart disease or chest pains and/ or you are receiving treatment to reduce high blood pressure, as MabCampath may make these conditions worse.
• imate bolno srce ali bolečine v prsnem košu in/ ali dobivate zdravila proti visokemu krvnemu tlaku, kajti zdravilo MabCampath lahko te težave poslabša.
• have been treated in the past with chemotherapies or general medications that have a high risk of causing heart damage, your doctor may wish to monitor your cardiac function (ECG, heart rate, body weight) while receiving MabCampath.
EKG, srčno frekvenco, telesno maso).
• have other side effects, most often blood disorders from taking MabCampath.
• imate druge neželene učinke, najpogosteje krvne motnje, zaradi jemanja zdravila MabCampath.
• are over 65 years of age as you may be more intolerant to the medicine than other patients.
• ste starejši od 65 let, kajti mogoče je, da boste zdravilo prenašali težje kot drugi bolniki.
You may experience an allergic or hypersensitivity reaction to MabCampath solution, especially against the protein contained in it, while the infusion is given to you.
Po infundiranju, se lahko pojavi alergična ali preobčutljivostna reakcija na raztopino MabCampath in še posebej na beljakovino, ki jo vsebuje.
Your doctor will treat you for this, if this happens.
V tem primeru vas bo zdravil zdravnik.
If you are a male or female of childbearing potential, then you should ensure that you use a reliable form of birth control during and for at least 6 months after treatment.
Če ste moški ali ženska v rodni dobi, morate poskrbeti, da boste med zdravljenjem in vsaj še 6 mesecev po njem uporabljali učinkovito kontracepcijo.
This is because the effects of MabCampath on reproduction are unknown.
Vpliv zdravila MabCampath na sposobnost razmnoževanja ni znan.
The safety and efficacy of MabCampath has not been established in children (below 17 years of age) or in patients who have kidney or liver disorders.
Varnost in učinkovitost zdravila MabCampath nista ugotovljeni pri otrocih (mlajših od 17 let) in bolnikih z boleznimi ledvic ali jeter.
Thus, MabCampath is not recommended in children below 17 years of age.
Uporaba zdravila MabCampath pri otrocih, mlajših od 17 let ni priporočljiva.
In particular, you should not be given MabCampath within 3 weeks of taking any other anti-cancer agents.
Zlasti pomembno je, da zdravila MabCampath ne dobite prej kot 3 tedne pred oz. po drugih zdravilih proti raku.
Pregnancy
47 Nosečnost
MabCampath must not be administered to patients who are pregnant, therefore if you:
Nosečnice ne smejo dobivati zdravila MabCampath, zato morate:
45 • are pregnant or you think you may be pregnant, you should tell your doctor immediately. • are of childbearing potential, then you should avoid becoming pregnant by using effective contraceptive methods before you start treatment, during treatment and for 6 months after treatment.
• svojemu zdravniku takoj povedati, če ste noseči ali mislite, da ste noseči, • paziti, da ne zanosite, če ste v rodni dobi; pred začetkom zdravljenja, med zdravljenjem in še 6 mesecev po njem morate uporabljati učinkovito kontracepcijo.
You should stop breast-feeding when you start your treatment and you should not begin breast-feeding again until at least 4 weeks after you have finished your treatment and you have consulted your doctor on the matter.
Ne začnite znova dojiti prej kot 4 tedne po koncu zdravljenja; pred tem se morate posvetovati s svojim zdravnikom.
No studies of the effects of MabCampath have been performed.
Študij o učinkih zdravila MabCampath niso izvedli.
However, caution should be exercised as confusion and sleepiness have been reported.
Ker so poročali o pojavih zmedenosti in zaspanosti, morate biti pri uporabi zdravila MabCampath pozorni.
HOW MABCAMPATH IS USED
KAKO UPORABLJATI ZDRAVILO MABCAMPATH
MabCampath is contained in solution in a glass ampoule.
Zdravilo MabCampath je na voljo kot raztopina v stekleni ampuli.
The ampoule contents are added to a sodium chloride or glucose solution contained in a drip bag.
Vsebino ampule je treba dodati raztopini natrijevega klorida ali glukoze v infuzijski vrečki.
The lines from the drip bag are then connected directly into one of your veins (see also ‘ information intended for medical or healthcare professionals’).
Infundiranje poteka preko cevke iz infuzijske vrečke neposredno v eno od vaših ven (glejte tudi informacije namenjene zdravstvenemu osebju).
MabCampath solution goes directly into your bloodstream through a vein.
Raztopina zdravila MabCampath steče po veni neposredno v krvni obtok.
This is known as intravenous infusion.
Takšen način dajanja imenujemo intravensko infundiranje.
During the first week, 3 mg of MabCampath in the solution is given on Day 1, then 10 mg on Day 2 and then 30 mg on Day 3.
Prvi teden boste v raztopini 1. dan dobili 3 mg zdravila MabCampath, 2. dan 10 mg in 3. dan 30 mg.
MabCampath will continue to be given at 30 mg on each of 3 alternate days each week.
Potem boste vsak teden trikrat (vsak drugi dan) dobili po 30 mg zdravila MabCampath.
Your doctor will increase the dose of MabCampath slowly to reduce the possibility of you having side effects and to allow your body to tolerate MabCampath better.
Zdravnik bo počasi povečeval odmerek zdravila MabCampath in s tem zmanjšal možnost pojava neželenih učinkov; tako bo vaše telo bolje prenašalo zdravilo MabCampath.
The doctor will carefully monitor you and decide what are the appropriate amounts of MabCampath to give during your whole treatment period.
Zdravnik vas bo ves čas zdravljenja natančno nadzoroval in bo določal za vas primerni odmerek zdravila MabCampath.
The side effects mentioned below are usually due to MabCampath because it affects the body’ s immune system in general and reduces resistance to infection.
Spodaj navedeni neželeni učinki so ponavadi posledica zdravila MabCampath; ta prizadene telesni imunski sistem v celoti in zmanjša odpornost proti okužbam.
Some infections may be serious and sometimes fatal.
Nekatere okužbe so resne in včasih usodne.
Your doctor may give you other medicines or change your dosage to help to reduce any side effects (see section 2 “ Take Special care”).
48 Za zmanjšanje morebitnih neželenih učinkov vam bo zdravnik morda predpisal še druga zdravila ali vam bo spremenil odmerek (glejte poglavje 2.
If you are not sure what the side effects below are, ask your doctor to explain them to you.
Če ne veste dobro, kaj pomenijo spodaj navedeni neželeni učinki, se posvetujte z zdravnikom.
If any of the side effects gets serious, or if you notice any effects not mentioned below, tell your doctor or your pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželen učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
46 Very common side effects (affects more than 1 patient in 10):
Zelo pogosti (pojavijo se pri več kot 1 od 10 bolnikov)
Usually one or more of these effects happen during the first week after the start of treatment.
Ponavadi se prvi teden po začetku zdravljenja pojavi eden ali več teh učinkov.
• fever, shivering/ chills, sweating, nausea (feeling sick), vomiting, low blood pressure, low white/ red blood cell levels, generalised serious infection, blisters, low blood platelet levels, tiredness, rash, itching, red raised lesions on the skin, shortness of breath, headache, diarrhoea and loss of appetite.
• zvišana telesna temperatura, drgetanje/ mrzlica, znojenje, slabost, bruhanje, nizek krvni tlak, majhna raven belih/ rdečih krvnih celic, resna splošna okužba, mehurji, majhno število trombocitov, utrujenost, izpuščaj, srbenje, rdečkaste izbočene rane na koži, težko dihanje, glavobol, driska in izguba apetita.
Your doctor may give you additional antibiotic and/ or antiviral treatment to reduce the risk of development of this and other infections.
• pljučnica; po potrebi vam bo zdravnik predpisal antibiotik in/ ali protivirusno zdravilo, da bo zmanjšal tveganje za nastanek te in drugih okužb.
Common (affects 1 to 10 patients in 100):
Pogosti (pojavijo se pri 1 do 10 od 100 bolnikov)
• high blood pressure, fast heart rate, feeling your heart racing, blood vessel spasm • becoming red in the face, bruising of the skin • low number of white blood cells with or without fever, low number of platelets in the blood, low number of red blood cells • headache • taste changes • decreased sense of touch • dizziness, sensation of spinning, fainting, shaking or trembling movements, feeling restless • eye inflammation • pins and needles or burning sensation of the skin, itching, increased perspiration • pain in the abdomen, bleeding of the stomach and intestine, swelling • vomiting, irritation and/ or ulceration of the mouth region • abnormal liver function, constipation, indigestion, passing abdominal gas • inflammation, irritation and/ or tightness of the lungs, throat and/ or sinuses, too little oxygen reaching the body organs, shortness of breath, coughing, coughing up of blood • abnormal bleeding (e. g. in the stomach and intestine or within the head) • pain, redness or swelling at the site of injection • generally feeling unwell, weakness, tiredness, pain in various parts of the body (muscle, back, chest, bones, joints) • weight loss, dehydration, thirst, excess fluid in the body, low calcium or sodium levels, temperature change sensation • flu-like symptoms • abscess, skin rash, blistering of the skin • confusion, anxiety, depression, sleepiness, sleeplessness • infections such as pneumonia (bacterial), candidal (fungal), herpes and shingles (viral) and respiratory, urinary, gastro-intestinal and other general bacterial infections.
• visok krvni tlak, hiter srčni utrip, občutek razbijanja srca, žilni spazem • zardevanje obraza, podplutbe na koži • nizko število belih krvnih celic z ali brez vročine, nizko število trombocitov v krvi, nizko število rdečih krvnih celic • glavobol • spremembe okusa • zmanjšana občutljivost za dotik • omotica, vrtoglavica, omedlevica, drgetanje ali tresenje, nemir • vnetje oči • mravljinčenje in pekoč občutek na koži, srbenje, povečano znojenje • bolečine v trebuhu, krvavitev v želodcu in črevesju, otekanje • bljuvanje, draženje in/ ali razjede v predelu ust • nenormalno delovanje jeter, zaprtje, težave z želodcem, vetrovi • vnetje, draženje in/ ali tiščanje v pljučih, grlu in/ ali obnosnih votlinah, nezadostna preskrba telesnih organov s kisikom, oteženo dihanje, kašelj, izkašljevanje krvi • nenormalne krvavitve (npr. v želodcu, črevesju ali v glavi) • bolečine, pordelost ali otekanje na mestu infundiranja • splošno slabo počutje, šibkost, utrujenost, bolečine v različnih delih telesa (mišice, hrbet, prsni koš, kosti, sklepi) • hujšanje, dehidracija, žeja, zastajanje tekočine v telesu, nizka koncentracija kalcija ali natrija, motnje v zaznavanju temperature • gripi podobni simptomi • ognojek, izpuščaj na koži, mehurji na koži • zmedenost, tesnoba, depresija, zaspanost, nespečnost • okužbe kot so pljučnice (bakterijske okužbe), okužbe s kandido (glivične okužbe), herpes in pasovec (virusne okužbe) ter bakterijske okužbe dihal, sečil, prebavil in druge splošne bakterijske okužbe.
Uncommon (affects 1 to 10 patients in 1,000) may be more serious in nature and include:
Občasni (1 do 10 od 1. 000 bolnikov), ki so lahko resni • motnje kostnega mozga • bolezni srca (zastoj srca, srčni infarkt, srčna kongestija, nenormalno hiter srčni utrip, znižan srčni utrip, nepravilen srčni utrip, bolečine v prsnem košu)
• bone marrow disorders • heart disorders (heart stopping, heart attack, heart congestion, abnormally fast heart rate, reduced heart rate, irregular heart rate, chest pain) • blood disorders (low blood oxygen content, abnormal clotting, decreased protein, low potassium levels, low number of white blood cells) • high blood sugar • autoimmune reactions (inflammation of the thyroid) • bleeding and inflammation of the gums, nosebleeds • fluid in the lungs, difficulty breathing, runny nose, abnormal findings in the lungs, lymph gland disorders • nervousness 47 • decreased appetite • abnormal thinking • ringing sound in the ears • hiccups • deafness • hoarseness • dizziness • abnormal kidney function • diabetes • bladder and urine infection • viral infection of the eye • stomach ache, paralysis of the small bowel • impotence • fainting, unsteadiness, disorder in muscle tension • swelling around the eyes, inflammation of the eye (conjunctivitis) • sensitivity of the skin, skin rashes, allergic reactions (hypersensitivity) • pneumonia, shingles • diarrhoea • joint pain, muscle pain • serious generalised infection, bruising or swelling at the injection site, ring worm infection of the skin.
49 • krvne motnje (nizka vsebnost kisika, nenormalno strjevanje krvi, zmanjšana količina beljakovin, nizka koncentracija kalija, nizko število belih krvnih celic) • visok krvni sladkor • avtoimunske reakcije (vnetje ščitnice) • krvavenje in vnetje dlesni, krvavitev iz nosu • tekočino v pljučih, težko dihanje, nahod, nenormalni izvidi plučnega delovanja, bolezni bezgavk • razdražljivost • zmanjšan apetit • motnje mišljenja • zvonenje v ušesih • kolcanje • naglušnost • hripavost • vrtoglavica • nenormalno delovanje ledvic • sladkorna bolezen • okužbe mehurja in sečil • virusne očesne okužbe • bolečine v želodcu, paraliza tankega črevesja • impotenca • omedlevica, težave z ravnotežjem, motnje v mišični napetosti • otekanje okrog oči, vnetje veznice (konjuktivitis) • občutljivost kože, izpuščaji na koži, alergijske reakcije (preobčutljivost) • pljučnica, pasasti izpuščaj • driska • bolečine v sklepih • resno splošno okužbo, podplutbe ali otekline na mestu aplikacije, glivična okužba kože.
Rare (affects 1 to 10 patients in 10,000)
Redki (pojavijo se pri 1 do 10 od 10. 000 bolnikov)
• tumour lysis syndrome is a special disorder which may begin with pains in the side and blood in the urine • bleeding in the brain (intracranial haemorrhage).
• sindrom tumorskega razpada, ki se lahko začne z bolečinami v ledvenem predelu in prisotnostjo krvi v seču • krvavitev v možganih (intrakranialna krvavitev).
Serious side effects, including difficulty in breathing, inflammation of the lungs, extreme shortness of breath, fainting, heart attack, autoimmune phenomena, low red blood cell and low blood platelet levels have occurred with fatal outcome in rare cases.
Pojavili so se resni neželeni učinki, vključno s težkim dihanjem, vnetjem pljuč, izredno kratko sapo, omedlevico, srčnim napadom, avtoimunskimi pojavi, zmanjšanjem števila rdečih krvnih celic in zmanjšanjem števila trombocitov v krvi; v redkih primerih so bili ti učinki usodni.
Do not use MabCampath after the expiry date (EXP) which is stated on the outer carton and the ampoule label.
Zdravila MabCampath ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki ampule.
Medicines should not be disposed of via wastewater or household waste.
50 Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
What MabCampath contains
Kaj vsebuje zdravilo MabCampath
Each pack of MabCampath contains 3 ampoules.
Vsako pakiranje zdravila MabCampath vsebuje 3 ampule.
Bayer Schering Pharma AG, Müllerstrasse 178, D-13342 Berlin, Germany.
Bayer Schering Pharma AG, Müllerstrasse 178, D- 13342 Berlin, Nemčija.
България Байер България ЕООД Тел. +359 02 81 401 01
България Байер България ЕООД Тел. +359 02 81 401 01 Česká republika Bayer s. r. o.
Magyarország Bayer Hungária KFT Tel: +36 14 87 41 00
Magyarország Bayer Hungária KFT Tel: +36 14 87 41 00 Malta Alfred Gera and Sons Ltd.
Nederland Bayer B. V., Bayer Schering Pharma Tel. +31 (0)297-28 06 66
Tel + 356 21 44 62 05 Nederland Bayer B. V., Bayer Schering Pharma Tel. +31 (0) 297- 28 06 66
Ελλάδα Bayer Ελλάς ΑΒΕΕ Tηλ: +30 210 618 75 00
Tηλ: +30 210 618 75 00
If particulate matter is present or the solution is coloured, then the ampoule should not be used.
Če so v njej delci ali je obarvana, ampule ne smete uporabiti.
The required amount of the ampoule contents should be added, via a sterile, low-protein binding, non-fibre 5 μ m filter, to 100 ml of sodium chloride 9 mg/ ml (0.9%) solution for infusion or glucose (5%) solution for infusion.
Potrebno količino vsebine ampule je treba dodati prek sterilnega, nevlaknastega 5 μm filtra, ki malo veže beljakovine v 100 ml raztopine natrijevega klorida 9 mg/ ml (0, 9%) za infundiranje ali 5% raztopine glukoze za infundiranje.
Care should be taken to ensure the sterility of the prepared solution particularly as it contains no antimicrobial preservatives.
Pazite na sterilnost pripravljene raztopine, še zlasti ker ne vsebuje antimikrobnih konzervansov.
Other medicinal products should not be added to the MabCampath infusion solution or simultaneously infused though the same intravenous line.
52 Raztopini zdravila MabCampath ne smete dodati drugih zdravil in je tudi ne smete infundirati hkrati z drugimi zdravili po isti intravenski liniji.
The use of latex gloves and safety glasses is recommended to avoid exposure in case of breakage of the ampoule or other accidental spillage.
Tako boste preprečili izpostavljenost v primeru razbitja ampule ali drugega naključnega razlitja.
Women who are pregnant or trying to become pregnant should not handle MabCampath.
Ženske, ki so noseče ali načrtujejo nosečnost, ne smejo delati z zdravilom MabCampath.
Read all of this leaflet carefully before you start taking this medicine
Pred uporabo natančno preberite navodilo!
Take special care with MabCampath:
54 Bodite posebno pozorni pri uporabi zdravila MabCampath
52 • steroids, antihistamines or analgesics (treatment for fever) to help to reduce some of the side effects.
• steroide, antihistaminike ali analgetike (proti zvišani telesni temperaturi), ki bodo pomagali zmanjšati nekatere neželene učinke.
You may experience an allergic or hypersensitivity reaction to MabCampath solution, especially against the protein contained in it, while the infusion is given to you.
Po infundiranju se lahko pojavi alergična ali preobčutljivostna reakcija na raztopino MabCampath in še posebej na beljakovino, ki jo vsebuje.
Thus, MabCampath is not recommended in children below 17 years of age.
Varnost in učinkovitost zdravila MabCampath nista ugotovljeni pri otrocih (mlajših od 17 let) in bolnikih z boleznimi ledvic ali jeter. Uporaba zdravila MabCampath pri otrocih, mlajših od 17 let ni priporočljiva.
Pregnancy
55 Nosečnost
53 • are pregnant or you think you may be pregnant, you should tell your doctor immediately. • are of childbearing potential, then you should avoid becoming pregnant by using effective contraceptive methods before you start treatment, during treatment and for 6 months after treatment.
• svojemu zdravniku takoj povedati, če ste noseči ali mislite, da ste noseči, • paziti, da ne zanosite, če ste v rodni dobi; pred začetkom zdravljenja, med zdravljenjem in še 6 mesecev po njem morate uporabljati učinkovito kontracepcijo.
MabCampath is contained in solution in a glass vial.
Zdravilo MabCampath je na voljo kot raztopina v stekleni viali.